Article

miR-28 plus ibrutinib as a novel combination therapy for Diffuse Large B Cell Lymphoma

2022-09-28

Abstract excerpt

<h4>ABSTRACT</h4> Diffuse large B cell lymphoma (DLBCL) is the most common aggressive B cell lymphoma and accounts for nearly 40% of cases of B cell non-Hodgkin lymphoma. DLBCL is generally treated with R-CHOP chemotherapy, but many patients do not respond or relapse after treatment. Here, we analyzed the therapeutic potential of the tumor suppressor microRNA-28 (miR-28) for DLBCL, alone and in combination with t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9750d840-e38d-5f46-98f8-16df9788e07a
DOI: 10.1101/2022.09.27.509662

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

miR-28 plus ibrutinib as a novel combination therapy for Diffuse Large B Cell LymphomaDOI 10.1101/2022.09.27.509662Read

Targeting of ibrutinib resistance–driving pathways by miR-28 in ABC-DLBCLSemantic proximity Read

The Role of microRNAs as Potential Biomarkers in Diffuse Large B-Cell LymphomaSemantic proximity Read

Genetic Events Inhibiting Apoptosis in Diffuse Large B-cell LymphomaSemantic proximity Read

Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell LymphomaSemantic proximity Read

Diffuse large B cell lymphoma: molecular targeted therapy.Semantic proximity Read

microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell LymphomaSemantic proximity Read

microRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomasSemantic proximity Read

Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL)Semantic proximity Read

Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor.Semantic proximity Read

Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patientsSemantic proximity Read

Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphomaSemantic proximity Read

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphomaSemantic proximity Read